Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 316,189	$ 781,740
Restricted cash	78,479	77,473
Notes receivable	72,580	149,757
Accounts receivable, net of allowance for doubtful accounts	3,130,438	4,327,980
Inventories, net of inventory reserve	2,551,669	6,414,305
Advances to suppliers	494,450	565,295
Receivable from sale of subsidiary		2,791,590
Prepaid license fee - related party, net	497,872	663,830
Prepaid expenses and other	3,055,169	5,235,113
Assets of discontinued operations	218,232	209,926
Total current assets	10,415,078	21,217,009
OTHER ASSETS:
Property and equipment, net	7,746,203	21,563,420
Intangible assets, net	3,544,484	3,562,513
Total other assets	11,290,687	25,125,933
Total assets	21,705,765	46,342,942
CURRENT LIABILITIES:
Short-term bank loans	2,066,986	2,182,960
Bank acceptance notes payable	74,502	72,698
Convertible note payable	745,903	710,504
Accounts payable	3,987,676	4,254,598
Accrued expenses	344,363	779,948
Advances from customers	1,687,081	1,073,797
Due to related parties	1,382,568	1,257,505
Income taxes payable	61,556	60,065
Liabilities of discontinued operations	319,929	268,532
Total current liabilities	10,670,564	10,660,607
LONG-TERM LIABILITIES:
Long-term loan	210,983	244,910
Total liabilities	10,881,547	10,905,517
STOCKHOLDERS' EQUITY:
Common stock ($0.001 par value; 12,500,000 shares authorized; 9,122,729 and 7,449,123 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	9,123	7,449
Additional paid-in capital	58,203,963	58,452,131
Retained earnings	(52,339,233)	(27,492,559)
Statutory reserve	2,352,592	2,352,592
Accumulated other comprehensive income - foreign currency translation adjustment	3,340,006	2,657,614
Total stockholder's equity	11,566,451	35,977,227
Non-controlling interest	(742,233)	(539,802)
Total stockholders' equity	10,824,218	35,437,425
Total liabilities and stockholders' equity	21,705,765	46,342,942
Series A Preferred stock [Member]
STOCKHOLDERS' EQUITY:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; Series A Preferred stock ($0.001 par value; 10,000,000 shares authorized; 0 and 0 issued and outstanding at March 31, 2019 and December 31, 2018, respectively)